Table: Phoenixbio -Q1 group results

PhoenixBio

09/08/2019 08:00

Aug 9 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            288 mln             158 mln           1.69     
                 (+81.8 pct)         (+28.7 pct)      (+37.4 pct) 
  Operating      loss 81 mln        loss 171 mln        117 mln   
  Recurring      loss 78 mln        loss 164 mln        137 mln   
  Net            loss 78 mln        loss 165 mln        122 mln   
  EPS          loss 26.90 yen      loss 56.89 yen      41.94 yen  
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T